T cell activation leads to protein kinase Cθ-dependent inhibition of TGF-β signaling

Journal of Immunology

Volumn 185, Issue 3, 2010, Pages 1568-1576

  Giroux, Martin ^a,b   Delisle, Jean Sébastien ^a,b   O'Brien, Alan ^a,b   Hébert, Marie Josée ^b,c   Perreault, Claude ^a,b,d  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; IMMUNOLOGIC AGENT; PROTEIN KINASE C THETA; SMAD3 PROTEIN; SMAD7 PROTEIN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; ISOENZYME; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; PRKCQ PROTEIN, MOUSE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIPID RAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL CYCLE G0 PHASE; CELL MEMBRANE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; G0 PHASE; HUMANS; ISOENZYMES; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956398435     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000137     Document Type: Article

References (62)

1. Kalies, K., M. Blessenohl, J. Nietsch, and J. Westermann. 2006. T cell zones of lymphoid organs constitutively express Th1 cytokine mRNA: specific changes during the early phase of an immune response. J. Immunol. 176: 741-749. (Pubitemid 43099670)
2. Li, M. O., and R. A. Flavell. 2008. TGF-β: a master of all T cell trades. Cell 134: 392-404.
3. Ge, G., and D. S. Greenspan. 2006. BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein. J. Cell Biol. 175: 111-120.
4. Yang, Y. C., E. Piek, J. Zavadil, D. Liang, D. Xie, J. Heyer, P. Pavlidis, R. Kucherlapati, A. B. Roberts, and E. P. Böttinger. 2003. Hierarchical model of gene regulation by transforming growth factor β. Proc. Natl. Acad. Sci. USA 100: 10269-10274.
5. Massagué, J. 2000. How cells read TGF-β signals. Nat. Rev. Mol. Cell Biol. 1: 169-178.
6. Shi, Y., and J. Massagué. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
7. Massagué, J., J. Seoane, and D. Wotton. 2005. Smad transcription factors. Genes Dev. 19: 2783-2810.
8. Feng, X. H., and R. Derynck. 2005. Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21: 659-693.
9. Dong, M., and G. C. Blobe. 2006. Role of transforming growth factor-β in hematologic malignancies. Blood 107: 4589-4596.
10. Taylor, I. W., and J. L. Wrana. 2008. SnapShot: the TGFβ pathway interactome. Cell 133: 378.e1.
11. Letterio, J. J. 2005. TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene 24: 5701-5712.
12. Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat. Immunol. 7: 1157-1165.
13. Kang, J. S., C. Liu, and R. Derynck. 2009. New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol. 19: 385-394.
14. Di Guglielmo, G. M., C. Le Roy, A. F. Goodfellow, and J. L. Wrana. 2003. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat. Cell Biol. 5: 410-421.
15. Itoh, S., and P. ten Dijke. 2007. Negative regulation of TGF-β receptor/Smad signal transduction. Curr. Opin. Cell Biol. 19: 176-184.
16. Rubtsov, Y. P., and A. Y. Rudensky. 2007. TGFβ signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7: 443-453.
17. Saxena, V., D. W. Lienesch, M. Zhou, R. Bommireddy, M. Azhar, T. Doetschman, and R. R. Singh. 2008. Dual roles of immunoregulatory cytokine TGF-β in the pathogenesis of autoimmunity-mediated organ damage. J. Immunol. 180: 1903-1912.
18. Daley, S. R., J. Ma, E. Adams, S. P. Cobbold, and H. Waldmann. 2007. A key role for TGF-β signaling to T cells in the long-term acceptance of allografts. J. Immunol. 179: 3648-3654.
19. Baron, C., R. Somogyi, L. D. Greller, V. Rineau, P. Wilkinson, C. R. Cho, M. J. Cameron, D. J. Kelvin, P. Chagnon, D. C. Roy, et al. 2007. Prediction of graft-versus-host disease in humans by donor gene-expression profiling.PLoSMed. 4: e23.
20. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
21. Letterio, J. J., A. G. Geiser, A. B. Kulkarni, H. Dang, L. Kong, T. Nakabayashi, C. L. Mackall, R. E. Gress, and A. B. Roberts. 1996. Autoimmunity associated with TGF-β1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98: 2109-2119.
22. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181.
23. Li, M. O., S. Sanjabi, and R. A. Flavell. 2006. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25: 455-471.
24. Locke, N. R., S. J. Patterson, M. J. Hamilton, L. M. Sly, G. Krystal, and M. K. Levings. 2009. SHIP regulates the reciprocal development of T regulatory and Th17 cells. J. Immunol. 183: 975-983.
25. + T cells are constitutively inhibited by TGF β under steady-state conditions. J. Immunol. 178: 6931-6940.
26. Li, M. O., Y. Y. Wan, and R. A. Flavell. 2007. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26: 579-591.
27. Marie, J. C., D. Liggitt, and A. Y. Rudensky. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25: 441-454.
28. Blais, M. E., G. Gérard, M. M. Martinic, G. Roy-Proulx, R. M. Zinkernagel, and C. Perreault. 2004. Do thymically and strictly extrathymically developing T cells generate similar immune responses? Blood 103: 3102-3110.
29. Blais, M. E., S. Brochu, M. Giroux, M. P. Bélanger, G. Dulude, R. P. Sékaly, and C. Perreault. 2008. Why T cells of thymic versus extrathymic origin are functionally different. J. Immunol. 180: 2299-2312.
30. LeHoux, J. G., G. Dupuis, and A. Lefebvre. 2001. Control of CYP11B2 gene expression through differential regulation of its promoter by atypical and conventional protein kinase C isoforms. J. Biol. Chem. 276: 8021-8028.
31. Lin, A. H., J. Luo, L. H. Mondshein, P. ten Dijke, D. Vivien, C. H. Contag, and T. Wyss-Coray. 2005. Global analysis of Smad2/3-dependent TGF-β signaling in living mice reveals prominent tissue-specific responses to injury. J. Immunol. 175: 547-554.
32. + immature dendritic cells in the lymph node paracortex. J. Immunol. 179: 4492-4502.
33. Caron, É., R. Charbonneau, G. Huppé, S. Brochu, and C. Perreault. 2005. The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. Int. Immunol. 17: 1583-1596.
34. Varelas, X., R. Sakuma, P. Samavarchi-Tehrani, R. Peerani, B. M. Rao, J. Dembowy, M. B. Yaffe, P. W. Zandstra, and J. L. Wrana. 2008. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 10: 837-848.
35. Abraham, R. T., and A.Weiss. 2004. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308.
36. Lin, J., and A. Weiss. 2001. T cell receptor signalling. J. Cell Sci. 114: 243-244.
37. Baier, G. 2003. The PKC gene module: molecular biosystematics to resolve its T cell functions. Immunol. Rev. 192: 64-79.
38. Tan, S. L., and P. J. Parker. 2003. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem. J. 376: 545-552.
39. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404: 402-407.
40. 2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197: 1525-1535.
41. Minami, Y., L. E. Samelson, and R. D. Klausner. 1987. Internalization and cycling of the T cell antigen receptor: role of protein kinase C. J. Biol. Chem. 262: 13342-13347.
42. von Essen, M., M. W. Nielsen, C. M. Bonefeld, L. Boding, J. M. Larsen, M. Leitges, G. Baier, N. Odum, and C. Geisler. 2006. Protein kinase C (PKC) α and PKC θ are the major PKC isotypes involved in TCR down-regulation. J. Immunol. 176: 7502-7510.
43. Chen, Y. G. 2009. Endocytic regulation of TGF-β signaling. Cell Res. 19: 58-70.
44. Maldonado, R. A., D. J. Irvine, R. Schreiber, and L. H. Glimcher. 2004. A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature 431: 527-532.
45. Maldonado, R. A., M. A. Soriano, L. C. Perdomo, K. Sigrist, D. J. Irvine, T. Decker, and L. H. Glimcher. 2009. Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse. J. Exp. Med. 206: 877-892.
46. Burack, W. R., K. H. Lee, A. D. Holdorf, M. L. Dustin, and A. S. Shaw. 2002. Cutting edge: quantitative imaging of raft accumulation in the immunological synapse. J. Immunol. 169: 2837-2841.
47. Chen, C. L., W. H. Hou, I. H. Liu, G. Hsiao, S. S. Huang, and J. S. Huang. 2009. Inhibitors of clathrin-dependent endocytosis enhance TGFβ signaling and responses. J. Cell Sci. 122: 1863-1871.
48. Berg-Brown, N. N., M. A. Gronski, R. G. Jones, A. R. Elford, E. K. Deenick, B. Odermatt, D. R. Littman, and P. S. Ohashi. 2004. PKCθ signals activation versus tolerance in vivo. J. Exp. Med. 199: 743-752.
49. Wang, L., Z. Xiang, L. L. Ma, Z. Chen, X. Gao, Z. Sun, P. Williams, R. S. Chari, and D. P. Yin. 2009. Deficiency of protein kinase C-θ facilitates tolerance induction. Transplantation 87: 507-516.
50. Valenzuela, J. O., C. Iclozan, M. S. Hossain, M. Prlic, E. Hopewell, C. C. Bronk, J. Wang, E. Celis, R. W. Engelman, B. R. Blazar, et al. 2009. PKCθ is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. J. Clin. Invest. 119: 3774-3786.
51. Tsukazaki, T., T. A. Chiang, A. F. Davison, L. Attisano, and J. L. Wrana. 1998. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 95: 779-791.
52. Goto, D., H. Nakajima, Y. Mori, K. Kurasawa, N. Kitamura, and I. Iwamoto. 2001. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-β/Smad3-mediated signaling. Biochem. Biophys. Res. Commun. 281: 1100-1105.
53. Brown, K. A., J. A. Pietenpol, and H. L. Moses. 2007. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-β signaling. J. Cell. Biochem. 101: 9-33.
54. Song, K., S. C. Cornelius, M. Reiss, and D. Danielpour. 2003. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-β by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J. Biol. Chem. 278: 38342-38351.
55. Remy, I., A. Montmarquette, and S. W. Michnick. 2004. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat. Cell Biol. 6: 358-365.
56. McKarns, S. C., R. H. Schwartz, and N. E. Kaminski. 2004. Smad3 is essential for TGF-β1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J. Immunol. 172: 4275-4284.
57. Nakao, A., M. Afrakhte, A. Morén, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin, and P. ten Dijke. 1997. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389: 631-635.
58. Nagarajan, R. P., J. Zhang, W. Li, and Y. Chen. 1999. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J. Biol. Chem. 274: 33412-33418.
59. Monteleone, G., A. Kumberova, N. M. Croft, C. McKenzie, H. W. Steer, and T. T. MacDonald. 2001. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108: 601-609.
60. Kanamaru, Y., A. Nakao, M. Mamura, Y. Suzuki, I. Shirato, K. Okumura, Y. Tomino, and C. Ra. 2001. Blockade of TGF-β signaling in T cells prevents the development of experimental glomerulonephritis. J. Immunol. 166: 2818-2823. (Pubitemid 32173523)
61. high regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J. Immunol. 171: 1140-1147.
62. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.